Differential expression of survivin and its splice variants, survivin-ΔEx3 and survivin-2B, in bladder cancer

Cancer Detection and Prevention

Volumn 32, Issue 4, 2009, Pages 308-313

  Atlasi, Yaser ^a   Mowla, Seyed Javad ^a   Ziaee, Seyed Amir Mohsen ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bladder cancer; Splice variants; Survivin; Survivin Ex3

Indexed keywords

ISOPROTEIN; SURVIVIN; SURVIVIN 2B; UNCLASSIFIED DRUG;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; BLADDER CANCER; CANCER INVASION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA SEQUENCE; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN VARIANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SEQUENCE ANALYSIS; TISSUE SECTION; TRANSITIONAL CELL CARCINOMA;

ALTERNATIVE SPLICING; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, TRANSITIONAL CELL; GENETIC VARIATION; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTEIN ISOFORMS; URINARY BLADDER NEOPLASMS;

EID: 60749107432     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2008.12.001     Document Type: Article

References (24)

1. Ambrosini G., Adida C., and Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3 (1997) 917-921
2. Velculescu V.E., Madden S.L., Zhang L., Lash A.E., Yu J., Rago C., et al. Analysis of human transcriptomes. Nat Genet 23 (1999) 387-388
3. Mahotka C., Wenzel M., Springer E., Gabbert H.E., and Gerharz C.D. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res 59 (1999) 6097-6102
4. Badran A., Yoshida A., Ishikawa K., Goi T., Yamaguchi A., Ueda T., et al. Identification of a novel splice variant of the human anti-apoptosis gene survivin. Biochem Biophys Res Commun 314 (2004) 902-907
5. Islam A., Kageyama H., Hashizume K., Kaneko Y., and Nakagawara A. Role of survivin, whose gene is mapped to 17q25, in human neuroblastoma and identification of a novel dominant-negative isoform, survivin-beta/2B. Med Pediatr Oncol 35 (2000) 550-553
6. Mostofi F.K., Sobin L.H., and Torloni H. Histologic typing of urinary bladders. International histological classification of tumors (1973), World Health Organization, Geneva p. 36
7. Atlasi Y., Mowla S.J., Ziaee S.A., and Bahrami A.R. OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer 120 (2007) 1598-1602
8. Hollander M., and Wolfe D.A. Nonparametric statistical methods. 2nd ed. (1999), John Wiley & Sons, Inc., New York
9. Hogg R.V., and Craig A.T. Introduction to mathematical statistics. 5th ed. (1995), Macmillan, New York
10. Smith S.D., Wheeler M.A., Plescia J., Colberg J.W., Weiss R.M., and Altieri D.C. Urine detection of survivin and diagnosis of bladder cancer. JAMA 285 (2001) 324-328
11. Shariat S.F., Casella R., Khoddami S.M., Hernandez G., Sulser T., Gasser T.C., et al. Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. J Urol 171 (2004) 626-630
12. Schultz I., Kiemeney L., Karthaus H., Witjes J.A., Willems J., Swinkels D., et al. Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas. Clin Chem 50 (2004) 1425-1428
13. Schultz I., Kiemeney L., Witjes J.A., Schalken J., Willems J., Swinkels D., et al. Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence. Anticancer Res 23 (2003) 3327-3331
14. Ryan B., O'Donovan N., Browne B., O'Shea C., Crown J., Hill A.D., et al. Expression of survivin and its splice variants survivin-2B and survivin-deltaEx3 in breast cancer. Br J Cancer 92 (2005) 120-124
15. Krieg A., Mahotka C., Krieg T., Grabsch H., Muller W., Takeno S., et al. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression. Br J Cancer 86 (2002) 737-743
16. Meng H., Lua C., Mabuchi H., and Tanigawa N. Prognostic significance and different properties of survivin splicing variants in gastric cancer. Cancer Lett 216 (2004) 147-155
17. Weikert S., Christoph F., Schrader M., Krause H., Miller K., and Muller M. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis. Int J Cancer 116 (2005) 100-104
18. Lehner R., Lucia M.S., Jarboe E.A., Orlicky D., Shroyer A.L., McGregor J.A., et al. Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma. Appl Immunohistochem Mol Morphol 10 (2002) 134-138
19. Altieri D.C. Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3 (2003) 46-54
20. Adida C., Crotty P.L., McGrath J., Berrebi D., Diebold J., and Altieri D.C. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 152 (1998) 43-49
21. Tran J., Rak J., Sheehan C., Saibil S.D., LaCasse E., Korneluk R.G., et al. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun 264 (1999) 781-788
22. Monzo M., Rosell R., Felip E., Astudillo J., Sanchez J.J., Maestre J., et al. A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol 17 (1999) 2100-2104
23. Zhang T., Otevrel T., Gao Z., Gao Z., Ehrlich S.M., Fields J.Z., et al. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 62 (2001) 8664-8667
24. Caldas H., Jiang Y., Holloway M.P., Fangusaro J., Mahotka C., Conway E.M., et al. Survivin splice variants regulate the balance between proliferation and cell death. Oncogene 12 (2005) 1994-2007